Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Žan Toplak; Louise Antonia Hendrickx; Reham Abdelaziz; Xiaoyi Shi; Steve Peigneur; Tihomir Tomašič; Jan Tytgat; Lucija Peterlin-Mašič; Luis A. Pardo

Journal title: Medicinal Research Reviews

Journal number: 42, 1

Journal publisher: John Wiley & Sons Inc.

Published year: 2022

Published pages: 183-226

DOI identifier: 10.1002/med.21808

ISSN: 0198-6325